男性痛风患者血清尿酸水平与载脂蛋白B的关系研究
Study on the Relationship between Serum Uric Acid Level and Apolipoprotein B in Male Patients with Gout
DOI: 10.12677/ACM.2021.118553, PDF,   
作者: 李 洁, 王颜刚, 李海铭, 王忠超*:青岛大学附属医院内分泌与代谢性疾病科,山东 青岛;杨玉媛:青岛大学附属医院老年医学科,山东 青岛
关键词: 男性痛风血清尿酸载脂蛋白BMale Gout Serum Uric Acid Apolipoprotein B
摘要: 目的:探讨男性痛风(Gout)患者血清尿酸(SUA)水平与载脂蛋白B (ApoB)的关系。方法:回顾性选取2019年1月1日至2021年3月31日于青岛大学附属医院内分泌与代谢性疾病科就诊的住院患者以及门诊患者,纳入符合条件的男性痛风患者73例。根据《中国高尿酸血症与痛风诊疗指南(2019)》要求,将患者分为SUA达标组(19例)和SUA升高组(54例),比较组间差异。采用Pearson相关分析SUA和ApoB的相关性,利用logistic回归模型进行相关危险因素分析。结果:与SUA达标组相比,SUA升高组ApoB的平均水平升高,差异有统计学意义(P < 0.05)。Pearson相关性分析显示ApoB与SUA呈正相关。单因素logistic回归分析显示,男性痛风患者SUA水平升高是ApoB的危险因素(OR = 0.986, 95% CI 0.979~0.993, P < 0.001);当校正年龄、空腹血糖(FBG)、身体质量指数(BMI)等因素后,两者关系仍然成立。结论:男性痛风患者SUA与ApoB相关,当SUA水平升高时,可导致ApoB水平升高。
Abstract: Objective: To explore the relationship between serum uric acid (SUA) and apolipoprotein B (Apo B) in male gout patients. Methods: A total of 73 eligible male patients with gout were retrospectively selected from the inpatients and outpatients who were admitted to the Department of Endocrinology and Metabolism Diseases of the Affiliated Hospital of Qingdao University on January 1, 2019 and March 31, 2021. According to the requirements of the “Guidelines for the Diagnosis and Treatment of Hyperuricemia and Gout in China (2019)”, patients were divided into the SUA standard group (19 cases) and the SUA elevated group (54 cases), and the differences between the groups were compared. Pearson correlation analysis was used to analyze the correlation between SUA and ApoB, and logistic regression model was used to analyze related risk factors. Results: Compared with the SUA level up to standard group, the average level of ApoB in the high SUA group increased, and the difference was statistically significant (P < 0.05). Pearson correlation analysis showed that ApoB was positively correlated with SUA. Univariate logistic regression analysis showed that elevated SUA level was a risk factor for ApoB in male patients with gout (OR = 0.986, 95% CI 0.979~0.993, P < 0.001). After adjusting for age, fasting blood glucose (FBG), body mass index (BMI) and other factors, the relationship still held. Conclusion: SUA is related to ApoB in male patients with gout. When the level of SUA increases, it can cause the level of ApoB to increase.
文章引用:李洁, 杨玉媛, 王颜刚, 李海铭, 王忠超. 男性痛风患者血清尿酸水平与载脂蛋白B的关系研究[J]. 临床医学进展, 2021, 11(8): 3765-3771. https://doi.org/10.12677/ACM.2021.118553

参考文献

[1] Luk, A.J. and Simkin, P.A. (2005) Epidemiology of Hyperuricemia and Gout. The American Journal of Managed Care, 11, S435-S442.
[2] Mackenzie, I.S., Ford, I., Nuki, G., Hallas, J., Hawkey, C.J., Webster, J., et al. (2020) Long-Term Cardiovascular Safety of Febuxostat Compared with Allopurinol in Patients with Gout (FAST): A Multicentre, Prospective, Randomised, Open-Label, Non-Inferiority Trial. The Lancet (London, England), 396, 1745-1757. [Google Scholar] [CrossRef
[3] Wu, M., Tian, Y., Wang, Q. and Guo, C. (2020) Gout: A Disease Involved with Complicated Immunoinflammatory Responses: A Narrative Review. Clinical Rheumatology, 39, 2849-2859. [Google Scholar] [CrossRef] [PubMed]
[4] Dehlin, M. and Jacobsson, L. (2020) Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nature Reviews Rheumatology, 16, 380-390. [Google Scholar] [CrossRef] [PubMed]
[5] Singh, J.A. and Gaffo, A. (2020) Gout Epidemiology and Comorbidities. Seminars in Arthritis and Rheumatism, 50, S11-S16. [Google Scholar] [CrossRef] [PubMed]
[6] Liang, J., Jiang, Y., Huang, Y., Song, W., Li, X., Huang, Y., et al. (2020) The Comparison of Dyslipidemia and Serum Uric Acid in Patients with Gout and Asymptomatic Hyperuricemia: A Cross-Sectional Study. Lipids in Health and Disease, 19, 31. [Google Scholar] [CrossRef] [PubMed]
[7] Ayoade, G.O. and Kuti, M.A. (2019) Defining Apolipoprotein B Treatment Targets. Nigerian Journal of Clinical Practice, 22, 355-360.
[8] Neogi, T., Jansen, T.L., Dalbeth, N., Fransen, J., Schumacher, H.R., Berendsen, D., et al. (2015) 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis & Rheumatology (Hoboken, NJ), 67, 2557-2568. [Google Scholar] [CrossRef] [PubMed]
[9] Kuo, C.F., Grainge, M.J., Zhang, W. and Doherty, M. (2015) Global Epidemiology of Gout: Prevalence, Incidence and Risk Factors. Nature Reviews Rheumatology, 11, 649-662. [Google Scholar] [CrossRef] [PubMed]
[10] Primatesta, P., Plana, E. and Rothenbacher, D. (2011) Gout Treatment and Comorbidities: A Retrospective Cohort Study in a Large US Managed Care Population. BMC Musculoskeletal Disorders, 12, 103. [Google Scholar] [CrossRef] [PubMed]
[11] Zheng, X., Gong, L., Luo, R., Chen, H., Peng, B., Ren, W., et al. (2017) Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Non-Obesity Chinese Adults. Lipids in Health and Disease, 16, 202. [Google Scholar] [CrossRef] [PubMed]
[12] Ali, N., Rahman, S. and Islam, S. (2019) The Relationship between Serum Uric Acid and Lipid Profile in Bangladeshi Adults. BMC Cardiovascular Disorders, 19, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[13] Tao, M., Pi, X., Ma, X., Shi, Y., Zhang, Y., Gu, H., et al. (2019) Relationship between Serum Uric Acid and Clustering of Cardiovascular Disease Risk Factors and Renal Disorders among Shanghai Population: A Multicentre and Cross-Sectional Study. BMJ Open, 9, e025453. [Google Scholar] [CrossRef] [PubMed]
[14] Johannesen, C.D.L., Mortensen, M.B., Langsted, A. and Nordestgaard, B.G. (2021) Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology, 77, 1439-1450. [Google Scholar] [CrossRef] [PubMed]
[15] Sniderman, A.D., Thanassoulis, G., Glavinovic, T., Navar, A.M., Pencina, M., Catapano, A., et al. (2019) Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 4, 1287-1295. [Google Scholar] [CrossRef] [PubMed]
[16] Benn, M., Nordestgaard, B.G., Jensen, G.B. and Tybjaerg-Hansen, A. (2007) Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B: The Copenhagen City Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 661-670. [Google Scholar] [CrossRef
[17] Zhu, Y., Hu, Y., Huang, T., Zhang, Y., Li, Z., Luo, C., et al. (2014) High Uric Acid Directly Inhibits Insulin Signalling and Induces Insulin Resistance. Biochemical and Biophysical Research Communications, 447, 707-714. [Google Scholar] [CrossRef] [PubMed]
[18] DeFronzo, R.A. and Ferrannini, E. (1991) Insulin Resistance. A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease. Diabetes Care, 14, 173-194. [Google Scholar] [CrossRef] [PubMed]
[19] Fraile, J.M., Torres, R.J., de Miguel, M.E., Martínez, P., Lundelin, K.J., Vázquez, J.J., et al. (2010) Metabolic Syndrome Characteristics in Gout Patients. Nucleosides, Nucleotides & Nucleic Acids, 29, 325-329. [Google Scholar] [CrossRef] [PubMed]